Should Gilead Sciences, Inc. Pay a Dividend?
Shares of Gilead Sciences have skyrocketed over the past two years, propelling the company into the upper echelons of the healthcare sector in terms of market cap. With all of its new peer group offering a dividend, should Gilead follow suit?
3 Simple Reasons Doctors May Stick With Gilead Sciences Instead of AbbVie
Gilead Sciences hepatitis C drug Harvoni offers three important advantages over AbbVie's competing hepatitis C drug cocktail.
3 Biotech Growth Stocks You Can Buy Right Now
These three biotech growth stocks may have already delivered impressive gains to investors, but there could still be plenty of room left for them to head even higher.